Lithium for Painful Dystonia in Parkinson's Disease
Lancet 1:1377, Quinn,N.&Marsden,C.D., 1986
Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986
Parkinson's Disease in Patients with Alzheimer's Disease
Arch Neurol 43:662-664, Leverenz,J.&Sumi,S.M., 1986
On Heredity, Twins, & Parkinson's Disease
Ann Neurol 19:409-411, Duvoisin,R.C., 1986
Parkinson's Disease in Monozygotic Twins
Ann Neurol 19:405-408, Jankovic,J.&Reches,A., 1986
Monozygotic Twins with Parkinson's Disease
Ann Neurol 19:402-405, Koller,W.,et al, 1986
Vascular Parkinsonism & Periarteritis Nodosa
Neurol 36:874-875, Mayo,J.,et al, 1986
Autonomic Dysfunction in Parkinson's Disease
Neurol 36:73-75, Goetz,C.G.,et al, 1986
Lisuride Infusion Pump:A Device for the Treatment of Motor Fluctuations in Parkinson's Disease
Lancet 1:467-470, Obeso,J.A.,et al, 1986
Swallowing & Speech Production in Parkinson's Disease
Ann Neurol 19:238-287, Robbins,J.,et al, 1986
Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986
Fetal Neuronal Grafts in Monkeys Given Methylphenyltetrahydropyridine
Lancet 1:1125-1127, Redmond,D.E.,et al, 1986
Positron Emission Tomography in the Early Diagnosis of Huntington's Disease
Neurol 36:888-894, Hayden,M.R.,et al, 1986
The Diagnosis of Huntington's Disease
Neurol 36:1279-1283, Folstein,S.E.,et al, 1986
Huntington's Disease, Pathogenesis & Management
NEJM 315:1267-1276, Martin,J.B.&Gusella,J.F., 1986
Clinicopath. Conference
Pick's Disease of Brain, with Frontal Lobar Atrophy, Degen of Basal Ganglia, Case 16-1986, NEJM 314:, 101-,1986., 1986
The Clinical Features & Natural History of the Steele-Richardson-Olszewski Syndrome (Prog Supranuclear Palsy)
Neurol 36:1005-1006, Maher,E.R.,et al, 1986
Akathisia-Or not Sitting
BMJ 292:1034-1035, Szabadi,E., 1986
MPTP:A Neurotoxin Relevant to the Pathophysiology of Parkinson's Disease, The 1985 George Cotzias Lecture
Neurol 36:250-258, Snyder,S.H.&D'Amato,R.J., 1986
Parkinsonism, Tardive Dyskinesia, Akathisia, & Depression Induced by Flunarizine
Lancet 1:1303-1304, Chouza,C.,et al, 1986
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Paraquat & Parkinson's Disease
Neurol 36:1147, Koller,W.C., 1986
Pathologic Correlates of Dementia in Parkinson's Disease
Arch Neurol 43:991-995, Chui,H.C.,et al, 1986
PET Scan Investigations of Huntington's Disease:Cerebral Metabolic Corr. of Neuro & Funct Decline
Ann Neurol 20:296-303, Young,A.B.,et al, 1986
Disappearance of Parkinsonian Signs after Spontaneous Vascular"Thalamotomy"
Arch Neurol 43:815-817, Dubois,B.,et al, 1986
Parkinson's Disease
BMJ 293:379-382, Quinn,N.P.&Husain,F.A., 1986
Magnetic Resonance Imaging of the Midbrain in Parkinson's Disease
Ann Neurol 20:744-747, Duguid,J.R.,et al, 1986
Smoking & Parkinson's Disease, Search for a Dose-Response Relationship
Arch Neurol 43:774-778, Golve,L.I.,et al, 1986
Cigarette Smoking & Parkinson's Disease
Neurol 36:1490-1496, Baron,J.A., 1986
Mental Disorders in Parkinson's Disease
RI Med Jour 69:323-326, Rafal,R., 1986
Brain Dopamine Metabolism in Patients with Parkinson's Disease Measured with Positron Emission Tomography
JNNP 49:853-860, Leenders,K.L.,et al, 1986
A Case of Parkinsonism Following Striatal Lacunar Infarction
JNNP 49:1087-1088, Friedman,A.,et al, 1986
Parkinsonism Following Dystonia in Three Patients
Movement Disorders 1:151-157, Katchen,M.&Duvoisin,R.C., 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
Dystonia in Untreated Parkinsonism
Clin Neuropharmacol 9:293-297, LeWitt,P.A.,et al, 1986
Prevalence of Parkinson's Disease in the Biracial Population of Copiah County, Mississippi
Neurol 35:841-845, Schoenberg,B.S.,et al, 1985
Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985
Late-Onset Hallervorden-Spatz Disease Presenting as Familial Parkinsonism
Neurol 35:227-234, Jankovic,J.,et al, 1985
Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985
Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985
Reversible Parkinsonism Related to Meperidine
NEJM 312:509, Lieberman,A.N.,et al, 1985
Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985
The Gait Abnormality of Huntington's Disease
Neurol 35:1450-1454, Koller,W.C.&Trimble,J., 1985
Presymptomatic Testing for Huntington's Disease
JAMA 253:3286-3291, Bird,S.J., 1985
Genetic Prediction & Family Structure in Huntington's Chorea
BMJ 290:1929-1931, Harper,P.S.,et al, 1985
Atypical Presentation of Progressive Supranuclear Palsy
Ann Neurol 17:334-343, Davis,P.H.,et al, 1985
Treatment of Progressive Supranuclear Palsy with Tricyclic Antidepressants
Neurol 35:1189-1193, Newman,G.C., 1985
The Clinical Syndrome of Striatal Dopamine Deficiency, Parkinsonism Induced by MPTP
NEJM 312:1418-1421, Burns,R.S.,et al, 1985
Permanent Human Parkinsonism Due to 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP) :Seven Cases
Neurol 35:949-956, Ballard,P.A.,et al, 1985
Development of Malignant Melanoma after Levodopa Therapy for Parkinson's Disease, Report of Case & Review
Am J Med 79:119-121, Kochar,A.S., 1985